Microbial Pathogenicity, Disease Principles, Biotechnology, and Microbial Genetics: Study Notes

Mechanisms of Microbial Pathogenicity

Stages of Microbial Pathogenesis

To cause disease, a microbe must complete several sequential steps within the host. Each stage is critical for successful infection and disease progression.

• Portals of Entry: Microbes enter the host through specific routes, including mucous membranes (respiratory, gastrointestinal, genitourinary tracts, conjunctiva), skin (via follicles, glands, or boring parasites), and the parenteral route (injections, bites, cuts, surgery).

• Adherence: Microbes attach to host tissues using adhesins/ligands (e.g., LPS, pili, capsules) that bind to host cell receptors (carbohydrates or peptides).

• Penetration/Evasion of Host Defenses: Pathogens resist removal and immune responses, such as phagocytosis, using capsules, cell wall components, and enzymes.

• Damage to Host Cells: Pathogens cause direct damage or produce toxins that disrupt host cell function.

• Portals of Exit: Microbes leave the host via the same routes as entry, facilitating transmission (e.g., respiratory droplets, feces, urine, blood).

Virulence Quantification: LD50 vs. ID50

• ID50 (Infectious Dose 50): Number of microbes required to cause infection in 50% of test animals.

• LD50 (Lethal Dose 50): Number of microbes (or toxin amount) required to kill 50% of test animals.

• Distinction: ID50 measures infectivity; LD50 measures lethality.

Microbial Strategies for Pathogenicity

• Capsules: Inhibit phagocytosis, increasing virulence (e.g., Streptococcus pneumoniae).

• Cell Wall Components: M protein (attachment, anti-phagocytic), Opa protein (inhibits T helper cells), mycolic acid (resists digestion).

• Enzymes (Exoenzymes):

  • Leukocidins: Destroy white blood cells.

  • Coagulases: Induce clot formation for protection.

  • Hyaluronidase: Degrades connective tissue, aiding spread.

• Invasins: Surface proteins that rearrange host actin, facilitating entry into cells.

Host Cell Damage Mechanisms

• Direct Damage: Pathogen metabolism and replication kill host cells.

• Toxin Production: Toxins disrupt host physiology, causing symptoms like fever, diarrhea, or shock.

Exotoxins vs. Endotoxins

Exotoxins and endotoxins are two major classes of bacterial toxins with distinct properties.

Characteristic	Exotoxins	Endotoxins
Source	Mostly Gram-positive	Gram-negative
Chemistry	Proteins	Lipid A of LPS
Relation to Microbe	Secreted during log phase	Part of outer membrane; released on death
Fever?	No	Yes
Neutralized by Antitoxin?	Yes	No
LD50	Small (highly toxic)	Relatively large

• Types of Exotoxins:

  • A-B Toxins: Two-part toxins (A = active, B = binding). Examples: Botulinum, Tetanus, Cholera toxins.

  • Membrane-Disrupting Toxins: Form pores in host membranes (e.g., hemolysins, leukocidins).

  • Superantigens: Trigger excessive cytokine release (e.g., TSST-1), causing fever, shock, and death.

• Endotoxins: Released from Gram-negative bacteria upon cell death; cause fever and septic shock via cytokine induction (IL-1, TNF-α).

• LAL Assay: Limulus amoebocyte lysate test detects endotoxins using horseshoe crab blood.

Pathogenic Properties of Viruses

• Cytopathic Effects (CPE): Observable changes in host cells due to viral infection, including inhibition of macromolecular synthesis, formation of inclusion bodies, syncytia (giant cells), antigenic/chromosomal changes, and transformation (loss of contact inhibition).

• Immune Evasion: Viruses evade host defenses by hiding inside cells and altering host cell surfaces.

Principles of Disease and Epidemiology

Core Definitions

• Pathogenesis: Study of disease development.

• Infection: Growth of microorganisms in/on the body.

• Disease: Abnormal condition resulting from infection or presence of microbes in unusual locations.

• Pathology: Study of disease (structure and function changes in the body).

Microbiota and Symbiosis

• Normal Microbiota: Permanent, beneficial residents of the body (e.g., gut flora producing vitamin K).

• Transient Microbiota: Temporary residents, often opportunistic pathogens.

• Symbiotic Relationships:

  • Commensalism: One benefits, other unaffected.

  • Mutualism: Both benefit.

  • Parasitism: One benefits at the other's expense.

Classification and Occurrence of Diseases

• Communicable Disease: Spread from host to host.

• Noncommunicable Disease: Not spread between hosts.

• Incidence: New cases in a time period.

• Prevalence: Total cases at a specific time.

• Sporadic: Occasional cases.

• Endemic: Constantly present in a region.

• Epidemic: Sudden increase in cases.

• Pandemic: Worldwide epidemic.

Extent of Host Involvement

• Local Infection: Confined to a small area.

• Systemic Infection: Spread throughout the body.

• Focal Infection: Local infection that spreads systemically.

• Bacteremia: Bacteria in blood.

• Septicemia: Bacterial growth in blood.

• Toxemia/Viremia: Toxins/viruses in blood.

• Primary Infection: Initial acute infection.

• Secondary Infection: Follows a primary infection, often by opportunists.

• Subclinical Disease: No noticeable symptoms, but infection present.

Stages of Disease Progression

1. Incubation Period: Time between infection and first symptoms.

2. Prodromal Period: Mild, non-specific symptoms begin.

3. Period of Illness: Most severe, specific symptoms (acme = peak intensity).

4. Period of Decline: Symptoms subside as pathogen is controlled.

5. Period of Convalescence: Recovery and return to health.

Reservoirs and Transmission

• Reservoirs: Sources of infection (human carriers, animals, non-living like soil/water).

• Transmission Methods:

  • Contact: Direct (person-to-person), indirect (fomites), droplet (short-range aerosols).

  • Vehicle: Transmission via water, food, or air (long-range).

  • Vectors: Animals/insects (mechanical or biological transmission).

  • Vertical: Mother to offspring (transplacental, perinatal, breastfeeding).

  • Horizontal: Person-to-person (not parent to child).

Nosocomial (Healthcare-Associated) Infections

• Definition: Infections acquired in healthcare settings.

• Risk Factors: Compromised hosts, invasive procedures, transmission by staff or equipment.

• Prevention: Universal precautions, hand hygiene, sterilization, infection control committees.

Emerging Infectious Diseases (EID)

• Contributing Factors: Microbial evolution, antibiotic misuse, climate change, travel, ecological disruption, lapses in public health.

• Examples: West Nile virus, Ebola, antibiotic-resistant bacteria.

Molecular Foundations of Biotechnology and Recombinant DNA Technology

Core Concepts

• Biotechnology: Use of organisms or cell components to produce useful products (e.g., antibiotics, enzymes).

• Recombinant DNA (rDNA) Technology: Manipulation of genes to produce desired proteins.

• Genome: Complete genetic content of an organism.

• Selection: Culturing microbes with desired traits.

• Site-Directed Mutagenesis: Intentional alteration of DNA sequence to change protein function.

Tools of Recombinant DNA Technology

• Restriction Enzymes: Cut DNA at specific sequences, often producing sticky ends for recombination (e.g., EcoRI cuts at GAATTC).

• DNA Ligase: Joins DNA fragments to form recombinant molecules.

• Vectors: DNA carriers (plasmids, viruses) for gene transfer.

• Marker Genes: Allow identification of transformed cells (e.g., antibiotic resistance).

Key Laboratory Techniques

• Polymerase Chain Reaction (PCR): Amplifies DNA segments through cycles of denaturation (94°C), annealing (60°C), and extension (72°C).

• Complementary DNA (cDNA): Synthesized from mRNA using reverse transcriptase; lacks introns, facilitating expression in bacteria.

• Blue-White Screening: Differentiates recombinant from non-recombinant bacteria using X-gal and ampicillin.

DNA Analysis and Identification

• DNA Fingerprinting: Identifies organisms by unique DNA patterns.

• Southern Blotting: Detects specific DNA sequences after gel electrophoresis and transfer to a membrane.

• DNA Probes: Labeled DNA fragments that hybridize to target sequences.

• Microarrays: Analyze expression of thousands of genes simultaneously.

New Technologies and Applications

• CRISPR-Cas9: Genome editing tool using guide RNA and Cas9 nuclease for targeted DNA cleavage and modification.

• Therapeutic Applications: Production of human proteins, subunit and DNA vaccines, gene therapy.

• Forensic Microbiology: Uses real-time PCR and RT-PCR for rapid identification of pathogens.

Fundamentals of Microbial Genetics and Gene Expression

Genetic Information and Flow

• Genetics: Study of heredity and gene function in microbes.

• Gene: DNA segment coding for a protein.

• Genetic Code: Triplet codons specify amino acids.

• Gene Expression: DNA directs protein synthesis via transcription and translation.

DNA Replication

• Initiation: Begins at origins of replication, forming replication bubbles.

• Enzymes:

  • Helicase: Unwinds DNA.

  • Single-strand binding protein: Stabilizes unwound DNA.

  • Topoisomerase: Relieves supercoiling.

  • Primase: Synthesizes RNA primer.

  • DNA Polymerase III: Synthesizes new DNA (leading and lagging strands).

  • DNA Polymerase I: Replaces RNA primers with DNA.

  • DNA Ligase: Joins Okazaki fragments.

• Leading Strand: Synthesized continuously.

• Lagging Strand: Synthesized discontinuously as Okazaki fragments.

Equation for DNA Synthesis:

$\text{(DNA)}_n + \text{dNTP} \rightarrow \text{(DNA)}_{n+1} + \text{PP}_i$

Transcription and Translation

• Transcription: RNA polymerase synthesizes RNA from DNA template, starting at promoter and ending at terminator.

• Translation: Ribosomes use mRNA to assemble amino acids into proteins. tRNA brings amino acids; rRNA forms ribosome structure.

• Start Codon: AUG (methionine).

• Stop Codons: UAA, UAG, UGA.

• Degeneracy: Multiple codons code for the same amino acid.

RNA Processing

• Eukaryotes: Pre-mRNA modified with 5' cap, 3' poly-A tail, and splicing (removal of introns).

• Prokaryotes: No cap/tail; transcription and translation are often coupled.

Regulation of Gene Expression

• Repression (trp operon): End-product (tryptophan) binds repressor, blocking transcription (anabolic pathways).

• Induction (lac operon): Inducer (allolactose) inactivates repressor, allowing transcription (catabolic pathways).

• Catabolite Repression: High glucose inhibits lac operon via low cAMP; low glucose increases cAMP, activating CAP and enhancing transcription.

Mutations and Mutagens

• Mutation: Change in DNA sequence.

• Mutagen: Agent causing mutations (chemical, physical).

• Types:

  • Point Mutation: Single base change (silent, missense, nonsense).

  • Frameshift Mutation: Insertion/deletion shifts reading frame.

Genetic Recombination and Transfer

• Transformation: Uptake of naked DNA from environment.

• Transduction: DNA transfer via bacteriophage (generalized: random genes; specialized: genes near prophage).

• Conjugation: DNA transfer via direct contact (pili).

• Vertical Transfer: Parent to offspring.

• Horizontal Transfer: Between cells of same generation.

Plasmids and Transposons

• Plasmids: Small, circular DNA molecules; F plasmid (conjugation), R plasmid (antibiotic resistance).

• Transposons: Mobile genetic elements ("jumping genes") that can move within or between DNA molecules, sometimes carrying resistance genes.

Example: R plasmids can accumulate multiple antibiotic resistance genes via transposons, posing a challenge in clinical settings.

Additional info: Where definitions or details were not explicit in the source, standard academic context was provided for completeness.